Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?

• Clinical trials bring hope just as we enter breast cancer awareness month.
• Phase 3 trials from AstraZeneca show a 72% success rate in reducing the risk of death.
• Becoming a new standard of treatment could open the door to $1.8 billion in revenue.

Clinical trials bring hope just as we enter breast cancer awareness month.Phase 3 trials from AstraZeneca show a 72% success rate in reducing the risk of death.Becoming a new standard of treatment could open the door to $1.8 billion in revenue.